Hint mode is switched on Switch off
For swift navigation between sections

Ambrx Biopharma

PDF download

Choose all Reset all
Download Cancel
Organization name
Ambrx Biopharma Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Ambrx Biopharma Inc. operates as a biotech company. The Company focuses on discovering and developing a novel class of engineered precision biologics (EPBs) using our proprietary expanded genetic code technology platform that allows us to incorporate, in a site-specific manner, synthetic amino acids (SAAs) into proteins within living cells.

Awards

News

06/10/2023 Ambrx Biopharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
22/09/2023 Ambrx Biopharma: Termination Of A Material Definitive Agreement, Other Events
15/09/2023 Ambrx Biopharma: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
01/09/2023 Ambrx Biopharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
25/08/2023 Ambrx Biopharma: Other Events
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
2022
IV q eng
2021
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001836056
  • EIN
    93-2892120
Registration is required to get access.